Breast tumours are classified into one of four clinically pertinent molecular subtypes based on the joint status of the hormone receptors (oestrogen and progesterone) and human epidermal growth factors receptor 2 (HER2) [3,4]. The gene discussed is ERBB2; the disease is breast neoplasm.